IMATINIB MAINTENANCE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) FOR PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE (PH plus ) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

被引：0
|
作者：
Kebriaei, P. [1 ]
Chiattone, A. [1 ]
Saliba, R. [1 ]
Jones, D. [1 ]
Anderlini, P. [1 ]
Andersson, B. [1 ]
Khouri, I [1 ]
Worth, L. [1 ]
Ravandi, F. [1 ]
Thomas, D. [1 ]
Kantarjian, H. [1 ]
Hamerschlak, N. [2 ]
Rodrigues, M. [2 ]
de Lima, M. [1 ]
Giralt, S. [1 ]
Champlin, R. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Albert Einstein Israeli Hosp HIAE, Sao Paulo, Brazil
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2009.12.232
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
195
引用
收藏
页码：S230 / S230
页数：1
相关论文
共 50 条
  • [1] Allogeneic Hematopoietic Cell Transplantation (Allogeneic HCT) for Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (ALL)
    Burke, Michael J.
    Cao, Qing
    Trotz, Barb
    Weigel, Brenda
    Kumar, Ashish
    Smith, Angela
    Verneris, Michael R.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (07) : 1289 - 1294
  • [2] Feasibility and toxicity of nommyeloablative hematopoietic cell transplantation (HCT) with or without imatinib for Philadelphia chromosome (Ph+) acute lymphoblastic leukemia (ALL).
    Norasetthada, L
    Maris, MB
    Sandmaier, BM
    Maloney, DG
    Georges, G
    Druker, B
    Radich, J
    Storb, R
    BLOOD, 2004, 104 (11) : 346B - 347B
  • [3] Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) for Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (ALL)
    Burke, Michael
    Trotz, Barb
    Cao, Qing
    Weigel, Brenda
    Kumar, Ashish
    Smith, Angela
    Verneris, Michael
    BLOOD, 2009, 114 (22) : 1311 - 1311
  • [4] Imatinib and Hematopoietic Cell Transplantation in Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Im, H. J.
    Shin, J. H.
    Choi, E. S.
    Kang, S. H.
    Kim, H.
    Koh, K. N.
    Kim, B. R.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S186 - S186
  • [5] Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Othman, Tamer
    Li, Shanpeng
    Zhang, Jianying
    Pourhassan, Hoda
    Agrawal, Vaibhav
    Ngo, Dat
    Chen, Jason
    Farol, Leonardo
    Sahebi, Firoozeh
    Sandhu, Karamjeet
    Spielberger, Ricardo
    Marcucci, Guido
    Forman, Stephen J.
    Stein, Anthony S.
    Nakamura, Ryotaro
    Pullarkat, Vinod
    Mei, Matthew
    Aldoss, Ibrahim
    Koller, Paul
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (08) : 1636 - 1639
  • [6] Imatinib and Interferon-Alpha Maintenance Therapy for Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph plus ALL) Ineligible for Allogeneic Stem Cell Transplantation (SCT).
    Pfeifer, Heike
    Wassmann, Barbara
    Kaebisch, Andreas
    Luebbert, Michael
    Leimer, Lothar
    Giagounidis, Aristoteles
    Hoelzer, Dieter
    Ottmann, Oliver G.
    BLOOD, 2009, 114 (22) : 806 - 806
  • [7] Administration of imatinib in the first 90 days after allogeneic hematopoietic cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Chen Huan
    Liu Kai-yan
    Xu Lan-ping
    Liu Dai-hong
    Chen Yu-hong
    Shi Hong-xia
    Han Wei
    Zhan Xiao-hui
    Wang Yu
    Zhao Ting
    Huang Xiao-jun
    CHINESE MEDICAL JOURNAL, 2011, 124 (02) : 246 - 252
  • [8] Administration of imatinib in the first 90 days after allogeneic hematopoietic cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    CHEN Huan
    LIU Kai-yan
    XU Lan-ping
    LIU Dai-hong
    CHEN Yu-hong
    SHI Hong-xia
    HAN Wei
    ZHAN Xiao-hui
    WANG Yu
    ZHAO Ting
    HUANG Xiao-jun
    中华医学杂志（英文版）, 2011, (02) : 246 - 252
  • [9] ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (Allo-HCT) FOR PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIAS: IMPACT OF IMATINIB ON RISK OF RELAPSE AND SURVIVAL
    Burke, M. J.
    Trotz, B.
    Luo, X.
    DeFor, T. E.
    Burns, L. J.
    Baker, K. S.
    Weisdorf, D. J.
    Wagner, J. E.
    Verneris, M. R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 56 - 57
  • [10] Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Othman, Tamer
    Koller, Paul
    Tsai, Ni-Chun
    Yang, Dongyun
    Pourhassan, Hoda
    Agrawal, Vaibhav
    Ngo, Dat
    Chen, Jason
    Farol, Leonardo
    Spielberger, Ricardo
    Sahebi, Firoozeh
    Al Malki, Monzr M.
    Cai, Ji-Lian
    Sandhu, Karamjeet S.
    Mansour, Joshua
    Salhotra, Amandeep
    Ali, Haris
    Aribi, Ahmed
    Arslan, Shukaib
    Marcucci, Guido
    Forman, Stephen J.
    Stein, Anthony S.
    Nakamura, Ryotaro
    Pullarkat, Vinod
    Aldoss, Ibrahim
    Mei, Matthew
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (09) : 1680 - 1690
12345